| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TNF Receptor-Associated Factor 6 | 7 | 2009 | 37 | 1.130 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2012 | 190 | 0.890 |
Why?
|
| Osteoclasts | 5 | 2012 | 165 | 0.790 |
Why?
|
| RANK Ligand | 4 | 2012 | 119 | 0.720 |
Why?
|
| Oligopeptides | 2 | 2016 | 429 | 0.570 |
Why?
|
| Apoptosis | 7 | 2016 | 7591 | 0.510 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 2390 | 0.500 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 204 | 0.490 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2012 | 72 | 0.440 |
Why?
|
| Monocytes | 3 | 2012 | 788 | 0.400 |
Why?
|
| Gene Deletion | 3 | 2012 | 1442 | 0.400 |
Why?
|
| Necrosis | 1 | 2012 | 580 | 0.390 |
Why?
|
| Ubiquitin | 4 | 2011 | 344 | 0.360 |
Why?
|
| Signal Transduction | 12 | 2012 | 11965 | 0.350 |
Why?
|
| I-kappa B Kinase | 3 | 2008 | 250 | 0.350 |
Why?
|
| Lipopolysaccharides | 3 | 2009 | 558 | 0.340 |
Why?
|
| Interleukin-1 | 2 | 2008 | 461 | 0.310 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2007 | 32 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2012 | 1538 | 0.300 |
Why?
|
| Cell Line | 11 | 2012 | 5114 | 0.260 |
Why?
|
| Osteoblasts | 1 | 2007 | 370 | 0.260 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2004 | 20 | 0.250 |
Why?
|
| Lysine | 1 | 2006 | 422 | 0.250 |
Why?
|
| Phosphoproteins | 3 | 2004 | 1152 | 0.240 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2009 | 93 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1493 | 0.210 |
Why?
|
| Caspase Inhibitors | 1 | 2002 | 95 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 1678 | 0.190 |
Why?
|
| Ubiquitination | 5 | 2009 | 575 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2016 | 589 | 0.180 |
Why?
|
| Mice, Knockout | 5 | 2012 | 5710 | 0.170 |
Why?
|
| NF-kappa B | 5 | 2007 | 1549 | 0.160 |
Why?
|
| Cell Survival | 5 | 2012 | 3045 | 0.160 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2002 | 430 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 14289 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 5 | 2008 | 1487 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 2488 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1073 | 0.150 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2018 | 388 | 0.150 |
Why?
|
| Mice | 13 | 2012 | 34495 | 0.150 |
Why?
|
| Ubiquitinated Proteins | 1 | 2016 | 9 | 0.140 |
Why?
|
| Transcription Factor CHOP | 1 | 2016 | 25 | 0.140 |
Why?
|
| Pyrimidines | 3 | 2015 | 3518 | 0.140 |
Why?
|
| Pyrazoles | 2 | 2015 | 1471 | 0.140 |
Why?
|
| Cell Differentiation | 5 | 2012 | 4078 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 15862 | 0.140 |
Why?
|
| Adenine | 2 | 2015 | 631 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2006 | 1439 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2009 | 2054 | 0.120 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2012 | 77 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2008 | 1764 | 0.120 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 430 | 0.120 |
Why?
|
| Protein Binding | 4 | 2016 | 3438 | 0.120 |
Why?
|
| TNF Receptor-Associated Factor 2 | 3 | 2009 | 39 | 0.120 |
Why?
|
| Proteasome Inhibitors | 1 | 2015 | 231 | 0.120 |
Why?
|
| Animals | 14 | 2012 | 59536 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2002 | 2022 | 0.110 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 39 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 1265 | 0.110 |
Why?
|
| Piperidines | 2 | 2015 | 1035 | 0.110 |
Why?
|
| Splenomegaly | 1 | 2012 | 158 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 5395 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 1618 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 276 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2012 | 5637 | 0.100 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 170 | 0.100 |
Why?
|
| Zinc Fingers | 2 | 2009 | 205 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2012 | 271 | 0.100 |
Why?
|
| Karyotyping | 1 | 2012 | 1022 | 0.100 |
Why?
|
| Catalysis | 2 | 2007 | 250 | 0.090 |
Why?
|
| Binding Sites | 4 | 2011 | 2171 | 0.090 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2007 | 46 | 0.090 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2015 | 923 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2015 | 3536 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2009 | 854 | 0.080 |
Why?
|
| bcl-X Protein | 2 | 2015 | 196 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 943 | 0.080 |
Why?
|
| Phosphorylation | 5 | 2011 | 4804 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 142 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2002 | 184 | 0.080 |
Why?
|
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1 | 2008 | 118 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2232 | 0.070 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2007 | 23 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 334 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 14551 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2012 | 3033 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2015 | 1823 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 850 | 0.070 |
Why?
|
| Crystallography, X-Ray | 4 | 2009 | 627 | 0.070 |
Why?
|
| Humans | 20 | 2018 | 261506 | 0.070 |
Why?
|
| Proteins | 3 | 2002 | 1963 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2015 | 1756 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2008 | 478 | 0.070 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 639 | 0.060 |
Why?
|
| Piperazines | 2 | 2015 | 2101 | 0.060 |
Why?
|
| Aged | 5 | 2018 | 70117 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2008 | 677 | 0.060 |
Why?
|
| Histones | 1 | 2011 | 1466 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2008 | 1038 | 0.060 |
Why?
|
| Cytokines | 1 | 2012 | 2809 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2008 | 5270 | 0.060 |
Why?
|
| DNA Damage | 1 | 2011 | 1954 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 423 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2004 | 2819 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 70 | 0.050 |
Why?
|
| Caspase 7 | 1 | 2002 | 35 | 0.050 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2002 | 37 | 0.050 |
Why?
|
| Transfection | 2 | 2011 | 2944 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 226 | 0.050 |
Why?
|
| Ceramides | 1 | 2002 | 95 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 145 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2002 | 153 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2002 | 302 | 0.050 |
Why?
|
| Middle Aged | 4 | 2018 | 86204 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2008 | 1094 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2002 | 217 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 189 | 0.050 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 205 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 471 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2004 | 1682 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 4233 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 324 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2009 | 1258 | 0.050 |
Why?
|
| Male | 5 | 2018 | 123000 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 621 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 1555 | 0.040 |
Why?
|
| Female | 5 | 2018 | 141928 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 6915 | 0.040 |
Why?
|
| Thalidomide | 1 | 2002 | 569 | 0.040 |
Why?
|
| Mutation | 2 | 2016 | 15179 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2009 | 997 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 6089 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 3343 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2007 | 4821 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 1375 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2009 | 392 | 0.030 |
Why?
|
| B-Cell Activating Factor | 1 | 2015 | 25 | 0.030 |
Why?
|
| Bendamustine Hydrochloride | 1 | 2015 | 107 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 77950 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2015 | 92 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2015 | 116 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 5178 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 194 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 273 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 4757 | 0.030 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2002 | 136 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 3472 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2015 | 560 | 0.030 |
Why?
|
| Fatigue | 1 | 2018 | 1239 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 187 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2007 | 1732 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 607 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 4758 | 0.020 |
Why?
|
| RING Finger Domains | 1 | 2009 | 5 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2009 | 43 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 91 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2006 | 1271 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2002 | 1643 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6207 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 240 | 0.020 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2007 | 16 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2007 | 23 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 300 | 0.020 |
Why?
|
| Static Electricity | 1 | 2007 | 58 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2007 | 126 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 12926 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 2007 | 329 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 240 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 1082 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 336 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 591 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2002 | 2074 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 549 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 886 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 359 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 630 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 469 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 10001 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 1519 | 0.020 |
Why?
|
| Kidney | 2 | 2007 | 2146 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 750 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 644 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 702 | 0.020 |
Why?
|
| Caspases | 1 | 2008 | 661 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 15193 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2004 | 59 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 182 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2008 | 1665 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2006 | 875 | 0.010 |
Why?
|
| DNA Repair | 1 | 2011 | 1872 | 0.010 |
Why?
|
| Benzamides | 1 | 2008 | 1832 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2002 | 46 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2002 | 39 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2002 | 28 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2002 | 32 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 52 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 3254 | 0.010 |
Why?
|
| U937 Cells | 1 | 2002 | 171 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 355 | 0.010 |
Why?
|
| CD40 Antigens | 1 | 2002 | 104 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2002 | 124 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 311 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 259 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 741 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2007 | 1203 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 301 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 280 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 4307 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2002 | 269 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 798 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 21445 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 10331 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 29902 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 874 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 1385 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 1818 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 1879 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 6086 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 6150 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 4053 | 0.010 |
Why?
|